From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.
Hosted on MSN
ProVerum raises $80m to advance BPH stent system
ProVerum has closed an $80m Series B equity financing round, boosting commercialisation efforts for its ProVee system for benign prostatic hyperplasia (BPH). The funding round was led by MVM Partners, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results